Scher H - Search Results

1

Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.

Sumanasuriya S, Omlin A, Armstrong A, Attard G, Chi KN, Bevan CL, Shibakawa A, IJzerman MJ, De Laere B, Lolkema M, Lorente D, Luo J, Mehra N, Olmos D, Scher H, Soule H, Stoecklein NH, Terstappen LWMM, Waugh D, de Bono JS. Sumanasuriya S, et al. Among authors: scher h. Eur Urol Oncol. 2018 Jun;1(2):151-159. doi: 10.1016/j.euo.2018.02.009. Epub 2018 May 15. Eur Urol Oncol. 2018. PMID: 31100240 Free article. Review.

2

Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer.

Seidman AD, Scher HI, Petrylak D, Dershaw DD, Curley T. Seidman AD, et al. Among authors: scher hi. J Urol. 1992 Mar;147(3 Pt 2):931-4. doi: 10.1016/s0022-5347(17)37426-8. J Urol. 1992. PMID: 1371564 Clinical Trial.

3

Prostatic cancer: where do we go from here?

Scher H. Scher H. Curr Opin Oncol. 1991 Jun;3(3):568-74. Curr Opin Oncol. 1991. PMID: 1892925 Review.

4

Predicting biologic potential in prostate cancer.

Scher HI. Scher HI. Curr Opin Oncol. 1990 Jun;2(3):520-8. Curr Opin Oncol. 1990. PMID: 2092769 Review. No abstract available.

5

Post-therapy change in prostate-specific antigen levels as a clinical trial endpoint in hormone-refractory prostatic cancer: a trial with 10-ethyl-deaza-aminopterin.

Schultz PK, Kelly WK, Begg C, Liebertz C, Cohen L, Scher HI. Schultz PK, et al. Among authors: scher hi. Urology. 1994 Aug;44(2):237-42. doi: 10.1016/s0090-4295(94)80138-x. Urology. 1994. PMID: 7519382 Free article. Clinical Trial.

6

Prostate cancer in the era of prostate-specific antigen.

Scher HI, Fossa S. Scher HI, et al. Curr Opin Oncol. 1995 May;7(3):281-91. doi: 10.1097/00001622-199505000-00014. Curr Opin Oncol. 1995. PMID: 7544627 Review.

7

Prostate specific antigen decline after antiandrogen withdrawal: the flutamide withdrawal syndrome.

Kelly WK, Scher HI. Kelly WK, et al. Among authors: scher hi. J Urol. 1993 Mar;149(3):607-9. doi: 10.1016/s0022-5347(17)36163-3. J Urol. 1993. PMID: 7679759

8

Introduction: prostate cancer.

Scher HI. Scher HI. Semin Oncol. 1994 Oct;21(5):511-3. Semin Oncol. 1994. PMID: 7939744 No abstract available.

9

Prostate cancer: how can a common disease be so controversial?

Kelly WK, Scher HI. Kelly WK, et al. Among authors: scher hi. Curr Opin Oncol. 1994 May;6(3):318-31. Curr Opin Oncol. 1994. PMID: 8080862 Review.

10

Incorporating tumor biology into therapy for prostate cancer.

Bromberg J, Scher HI. Bromberg J, et al. Among authors: scher hi. Curr Opin Oncol. 1993 May;5(3):546-58. doi: 10.1097/00001622-199305000-00017. Curr Opin Oncol. 1993. PMID: 8494915 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

747 results

Search Page